Levetiracetam Pura

Levetiracetam, the active ingredient in Levetiracetam Pura, is an Anticonvulsant presented as an oral tablet for oral use and marketed in the European Union. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Pura as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, adhering to EU quality standards and providing reliable global logistics. The company ensures batch traceability and supports regulatory compliance for its customers.

Levetiracetam is an anticonvulsant medication used to manage several seizure types in epilepsy.

Partial seizures: reduces seizure frequency in patients with focal onset epilepsy. Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. Myoclonic seizures: decreases myoclonic jerks in appropriate seizure types.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of lightheadedness or imbalance. - Headache: mild to moderate head pain. - Irritability: changes in mood or increased agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Psychiatric symptoms: depression, suicidal thoughts, or severe mood changes. - Blood disorders: signs of low blood cell counts such as unusual bruising or bleeding.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal function: adjust dose in patients with impaired renal clearance. Pregnancy: limited data, weigh benefits against potential risks. Concomitant CNS depressants: monitor for enhanced sedation. Behavioral changes: observe for mood alterations or aggression. Drug interactions: review patient’s medication list for potential interactions. Store at ambient temperature: keep in original container, protect from moisture and heat.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression. - Other antiepileptic drugs: may require dose adjustments. - Oral contraceptives: possible reduction in contraceptive effectiveness.